查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968474

約翰氏症診斷市場－全球產業規模、佔有率、趨勢、機會、預測：按動物類型、檢測類型、最終用戶、地區和競爭對手分類，2021-2031年

Johne's Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type, By Test Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球約翰尼氏症診斷市場預計將從 2025 年的 6.7566 億美元成長到 2031 年的 9.8755 億美元，複合年成長率為 6.53%。

此領域包括專門用於識別牲畜群體中副結核分枝桿菌的檢測平台和分析方法，例如聚合酵素鏈鎖反應(PCR) 和酵素免疫分析法試驗 (ELISA)。推動這一領域發展的主要因素是迫切需要解決生產損失問題，特別是因感染牛早期淘汰和產奶量下降造成的損失。此外，嚴格的貿易通訊協定和牛健康認證計畫要求頻繁監測，迫使生產者維持定期篩檢計畫。例如，愛爾蘭動物健康協會 (Animal Health Ireland) 在 2024 年報告稱，該疾病每年給愛爾蘭酪農行業造成 1124 萬至 2385 萬歐元的損失，凸顯了有效診斷解決方案的必要性，這也凸顯了經濟風險。

市場概覽
預測期 2027-2031
市場規模：2025年 6.7566億美元
市場規模：2031年 9.8755億美元
複合年成長率：2026-2031年 6.53%
成長最快的細分市場 酵素連結免疫吸附試驗
最大的市場 北美洲

市場擴張的主要障礙在於現有診斷方法在疾病漫長的無症狀期敏感度不足。受感染動物通常產生的抗體水平極低，或多年持續排放少量細菌，導致假陰性結果頻繁，阻礙根除工作。這項早期感染檢測的技術難題會削弱生產者對篩檢的信心，從而減緩注重成本的畜牧場採用綜合檢測系統的步伐。

市場促進因素

快速血清學和分子診斷技術的創新正在從根本上改變市場格局，滿足了對檢測副結核分枝桿菌（Mycobacterium avium subspecies paratuberculosis）的靈敏度和速度的迫切需求。高通量PCR和噬菌體技術的進步顯著加快了活菌的鑑定速度，相較於以往耗時數月的培養方法，速度大幅提升。例如，2024年11月出版的《日誌 ）刊登了報導題為“一種檢測1日齡牛約翰尼氏病的新方法”的文章，報導了一種新型診斷系統，在75%的受試病例中，其檢測性行為感染的時間比標準糞便PCR檢測至少提前四周。這些進展對於切斷感染鏈至關重要，使養殖戶能夠在牛污染環境、損害生產指標之前將其隔離。

此外，政府強制推行的疾病控制和根除計畫是推動疾病防治的第二個主要因素，使得定期篩檢成為標準作業要求。這些法規結構通常將市場進入與牛群健康掛鉤，農民必須嚴格遵守檢查計畫才能維持貿易認證。正如發表在《預防獸醫學》（2024年8月）上的文章「英國酪農牛約翰尼病疫情十年變化」所指出的，監測數據顯示，平均檢測值最高的25%的牛佔所有陽性結果的42%，這凸顯了集中式方案在管理高風險牛群方面的重要性。此外，這些計劃還促進了綜合管理。根據2024年《乳品科學雜誌》的報道，將牛納入檢查通訊協定可將疾病傳播減少高達30%，這推動了全球對診斷試劑的需求。

市場挑戰

全球約翰尼病診斷市場發展面臨的主要障礙之一是現有檢測工具在疾病漫長的無症狀期靈敏度不足。受感染的牲畜往往攜帶副結核分枝桿菌多年，卻不表現出足夠的抗體反應或排放可檢測的細菌量，導致標準檢測經常出現假陰性結果。無法準確檢測這些早期攜帶者會削弱生產者對監測措施成本效益的信心。由於傳播源未被發現，即使投入大量篩檢資金也無法阻止後續疫情的爆發，因此畜牧業主往往不願投入資金進行能夠帶來市場收益的定期檢測。

這種懷疑態度也因數據顯示圈養牲畜群體中約翰氏症檢出率較低而進一步加劇。根據約翰氏症行動小組的數據，2024年英國監測牛的牛奶ELISA檢測平均陽性率為2.7%。雖然這一數字表明疫情控制有效，但也凸顯了診斷在發現更廣泛的無症狀感染方面面臨的挑戰，這阻礙了注重成本的農業企業廣泛實施主動篩檢通訊協定。

市場趨勢

人工智慧驅動的微型RNA生物標記技術的興起，正透過克服傳統血清學檢測固有的靈敏度限制，徹底改變全球約翰氏症診斷市場。與依賴延遲抗體產生的ELISA檢測不同， 微型RNA分析透過分析宿主反應基因表現，在無症狀攜帶者出現傳染性之前將其檢測出來。這種利用機器學習演算法的分子策略，能夠對標準檢測方法無法辨識的早期感染階段進行精準分類。根據2025年5月發表在DVM360上的報導《一種新的診斷方法有助於早期發現牛約翰氏症》，一種新近檢驗的人工智慧驅動的微型RNA模型在檢測I期和II期感染方面達到了71.8%的準確率，為識別無症狀攜帶者和阻斷感染循環提供了重要工具。

同時，診斷檢測與雲端畜群管理平台的整合正推動畜牧業從被動診斷轉向預測性風險分層。先進的軟體解決方案整合歷史檢測數據，產生動態風險評分，使生產者不僅能夠應對陽性結果，還能預測疾病進展。這種數位化支持演算法叢集，識別出可能被標準通訊協定忽略的高風險動物。根據2025年2月《農民周刊》發表的題為「新型數據分析工具提升約翰尼病風險檢測」的報導，預測分析顯示，特定高風險數據叢集中的動物感染約翰尼病的可能性比低風險組高出1000倍，這有助於實施預防性生物安全措施。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球約翰氏症診斷市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 動物種類（牛、山羊、綿羊）
    • 依檢測方法（ELISA、PCR、AGID 等）
    • 依最終使用者（獸醫院/診所、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美約翰氏症診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲約翰氏症診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區約翰氏症診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲約翰氏症診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲約翰氏症診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球約翰氏症診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Zoetis Inc.
  • Thermo Fisher Scientific, Inc.
  • PBD Biotech Ltd
  • IDEXX Laboratories, Inc.
  • Innovative Diagnostics SAS
  • VMRD Inc.
  • BIOMeRIEUX SA
  • INDICAL BIOSCIENCE GmbH
  • Tetracore, Inc.
  • Surefarm Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19114

The Global Johne's Disease Diagnostics Market is projected to expand from USD 675.66 Million in 2025 to USD 987.55 Million by 2031, registering a CAGR of 6.53%. This sector encompasses testing platforms and analytical assays, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assays (ELISA), specifically engineered to identify Mycobacterium avium subspecies paratuberculosis in livestock populations. The primary catalyst for this growth is the urgent need to address production losses, particularly those resulting from premature culling and diminished milk yields in infected herds. Additionally, strict trade protocols and herd health certification programs mandate frequent surveillance, forcing producers to maintain regular screening schedules. Highlighting the economic stakes, Animal Health Ireland reported in 2024 that the disease costs the Irish dairy industry between €11.24 million and €23.85 million annually, necessitating effective diagnostic solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 675.66 Million
Market Size 2031USD 987.55 Million
CAGR 2026-20316.53%
Fastest Growing SegmentELISA
Largest MarketNorth America

A major obstacle restricting broader market growth is the insufficient sensitivity of existing diagnostic methods during the disease's prolonged subclinical stage. Because infected animals often produce undetectable antibody levels or shed bacteria in low quantities for years, false-negative results are common, which hinders eradication efforts. This technical struggle to detect early-stage infection can erode producer trust in the efficacy of screening, subsequently postponing the widespread implementation of comprehensive testing regimes in cost-conscious livestock operations.

Market Driver

Technological innovations in rapid serological and molecular diagnostics are fundamentally transforming the market by satisfying the urgent requirement for sensitivity and speed in detecting Mycobacterium avium subspecies paratuberculosis. The rise of high-throughput PCR and phage-based technologies now permits the identification of viable bacteria significantly faster than legacy culture methods, which historically took months. For instance, the Animal Health Media Journal reported in November 2024, in an article titled 'New test detects Johne's disease in day-old calves,' that a novel diagnostic system could identify active infection at least four weeks sooner than standard fecal PCR in 75% of trial instances. These advancements are crucial for interrupting transmission chains, allowing farmers to isolate infectious stock before they contaminate the environment and harm production metrics.

Furthermore, the enforcement of Government-Mandated Disease Control and Eradication Programs acts as a secondary major driver, making regular screening a standard operational necessity. These regulatory frameworks frequently tie market access to herd health status, obliging farmers to follow rigorous testing schedules to preserve trade certifications. As noted in 'Changes in the Johne's Disease situation in GB dairy herds over 10 years' in Preventive Veterinary Medicine (August 2024), surveillance data indicated that the top 25% of herds with high average test values were responsible for 42% of all positive results, emphasizing the importance of centralized schemes in managing high-risk reservoirs. Moreover, these programs promote comprehensive management; according to the Journal of Dairy Science in 2024, incorporating young stock into testing protocols could decrease disease transmission by up to 30%, thereby boosting the global demand for diagnostic supplies.

Market Challenge

A significant impediment to the growth of the Global Johne's Disease Diagnostics Market is the inadequate sensitivity of existing tools during the disease's extended subclinical phase. Since infected livestock frequently carry Mycobacterium avium subspecies paratuberculosis for years without generating adequate antibody responses or shedding detectable bacterial loads, standard assays often return false-negative results. This inability to accurately detect early-stage carriers damages producer confidence regarding the cost-efficiency of surveillance initiatives. When significant investments in screening fail to stop subsequent outbreaks because of undetected spreaders, livestock owners often hesitate to commit to the recurring testing schedules that generate market revenue.

This skepticism is further bolstered by data demonstrating low detection rates within managed populations. According to the Action Group on Johne's, the mean prevalence of positive milk ELISA results in monitored herds across the United Kingdom was recorded at 2.7% in 2024. While this figure suggests effective management, it also underscores the challenge diagnostics face in revealing the broader reservoir of subclinical infection, thereby discouraging the widespread implementation of aggressive screening protocols among cost-sensitive farming operations.

Market Trends

The rise of AI-Powered MicroRNA Biomarker Technologies is revolutionizing the Global Johne's Disease Diagnostics Market by resolving the sensitivity limitations inherent in traditional serology. In contrast to ELISA tests, which depend on lagging antibody production, microRNA profiling examines host-response gene expression to detect subclinical carriers before they become infectious. Utilizing machine learning algorithms, this molecular strategy enables the precise classification of early infection stages that standard assays miss. As reported by DVM360 in May 2025, in the article 'New diagnostic approach may help detect Johne disease in cattle earlier,' a newly validated AI-driven microRNA model achieved 71.8% accuracy in detecting Stage I and II infections, providing a vital tool for identifying silent spreaders and breaking transmission cycles.

Simultaneously, the integration of diagnostic testing with cloud-based herd management platforms is moving the industry from reactive diagnosis toward predictive risk stratification. Advanced software solutions now compile historical testing data to produce dynamic risk scores, enabling producers to foresee disease progression rather than simply responding to positive results. This digital shift supports algorithmic clustering to pinpoint high-risk animals that might be overlooked by standard protocols. According to Farmers Weekly in February 2025, in the article 'Johne's risk detection improved with new data analysis tool,' predictive analytics showed that animals within specific high-risk data clusters were up to 1,000 times more likely to advance to an infectious state than low-risk counterparts, facilitating proactive biosecurity measures.

Key Market Players

  • Zoetis Inc.
  • Thermo Fisher Scientific, Inc.
  • PBD Biotech Ltd
  • IDEXX Laboratories, Inc.
  • Innovative Diagnostics SAS
  • VMRD Inc.
  • BIOMeRIEUX S.A.
  • INDICAL BIOSCIENCE GmbH
  • Tetracore, Inc.
  • Surefarm Ltd

Report Scope

In this report, the Global Johne's Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Johne's Disease Diagnostics Market, By Animal Type

  • Cattle
  • Goat
  • Sheep

Johne's Disease Diagnostics Market, By Test Type

  • ELISA
  • PCR
  • AGID
  • Others

Johne's Disease Diagnostics Market, By End User

  • Veterinary Hospitals & Clinics
  • Others

Johne's Disease Diagnostics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Johne's Disease Diagnostics Market.

Available Customizations:

Global Johne's Disease Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Johne's Disease Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal Type (Cattle, Goat, Sheep)
    • 5.2.2. By Test Type (ELISA, PCR, AGID, Others)
    • 5.2.3. By End User (Veterinary Hospitals & Clinics, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Johne's Disease Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal Type
    • 6.2.2. By Test Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Johne's Disease Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.2. By Test Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Johne's Disease Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal Type
        • 6.3.2.2.2. By Test Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Johne's Disease Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal Type
        • 6.3.3.2.2. By Test Type
        • 6.3.3.2.3. By End User

7. Europe Johne's Disease Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal Type
    • 7.2.2. By Test Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Johne's Disease Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal Type
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By End User
    • 7.3.2. France Johne's Disease Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal Type
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Johne's Disease Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal Type
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Johne's Disease Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal Type
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Johne's Disease Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal Type
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By End User

8. Asia Pacific Johne's Disease Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal Type
    • 8.2.2. By Test Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Johne's Disease Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal Type
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Johne's Disease Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal Type
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Johne's Disease Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal Type
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Johne's Disease Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal Type
        • 8.3.4.2.2. By Test Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Johne's Disease Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal Type
        • 8.3.5.2.2. By Test Type
        • 8.3.5.2.3. By End User

9. Middle East & Africa Johne's Disease Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal Type
    • 9.2.2. By Test Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Johne's Disease Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal Type
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Johne's Disease Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal Type
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Johne's Disease Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal Type
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By End User

10. South America Johne's Disease Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal Type
    • 10.2.2. By Test Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Johne's Disease Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal Type
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Johne's Disease Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal Type
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Johne's Disease Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal Type
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Johne's Disease Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zoetis Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc.
  • 15.3. PBD Biotech Ltd
  • 15.4. IDEXX Laboratories, Inc.
  • 15.5. Innovative Diagnostics SAS
  • 15.6. VMRD Inc.
  • 15.7. BIOMeRIEUX S.A.
  • 15.8. INDICAL BIOSCIENCE GmbH
  • 15.9. Tetracore, Inc.
  • 15.10. Surefarm Ltd

16. Strategic Recommendations

17. About Us & Disclaimer